These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 15275831

  • 1. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K, Dziubina A.
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [Abstract] [Full Text] [Related]

  • 2. Effect of adenosine A(2A) receptor antagonists on L-DOPA-induced hydroxyl radical formation in rat striatum.
    Gołembiowska K, Dziubina A, Kowalska M, Kamińska K.
    Neurotox Res; 2009 Feb; 15(2):155-66. PubMed ID: 19384578
    [Abstract] [Full Text] [Related]

  • 3. The effect of adenosine A(2A) receptor antagonists on hydroxyl radical, dopamine, and glutamate in the striatum of rats with altered function of VMAT2.
    Gołembiowska K, Dziubina A.
    Neurotox Res; 2012 Aug; 22(2):150-7. PubMed ID: 22407500
    [Abstract] [Full Text] [Related]

  • 4. Reserpine pretreatment prevents increases in extracellular striatal dopamine following L-DOPA administration in rats with nigrostriatal denervation.
    Kannari K, Tanaka H, Maeda T, Tomiyama M, Suda T, Matsunaga M.
    J Neurochem; 2000 Jan; 74(1):263-9. PubMed ID: 10617128
    [Abstract] [Full Text] [Related]

  • 5. Effect of the adenosine A2A receptor antagonist 8-(3-chlorostyryl)caffeine on L-DOPA biotransformation in rat striatum.
    Gołembiowska K, Dziubina A.
    Brain Res; 2004 Feb 20; 998(2):208-17. PubMed ID: 14751592
    [Abstract] [Full Text] [Related]

  • 6. Paradoxical effects of adenosine receptor ligands on hydroxyl radical generation by L-DOPA in the rat striatum.
    Gołembiowska K, Dziubina A, Kowalska M, Kamińska K.
    Pharmacol Rep; 2008 Feb 20; 60(3):319-30. PubMed ID: 18622056
    [Abstract] [Full Text] [Related]

  • 7. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS, Starr MS.
    Synapse; 1999 Oct 20; 34(1):36-46. PubMed ID: 10459170
    [Abstract] [Full Text] [Related]

  • 8. Effect of adenosine A(2A) receptor antagonists and L-DOPA on hydroxyl radical, glutamate and dopamine in the striatum of 6-OHDA-treated rats.
    Gołembiowska K, Dziubina A.
    Neurotox Res; 2012 Feb 20; 21(2):222-30. PubMed ID: 21830163
    [Abstract] [Full Text] [Related]

  • 9. The antiparkinsonian drug budipine stimulates the activity of aromatic L-amino acid decarboxylase and enhances L-DOPA-induced dopamine release in rat substantia nigra.
    Biggs CS, Fisher A, Starr MS.
    Synapse; 1998 Nov 20; 30(3):309-17. PubMed ID: 9776134
    [Abstract] [Full Text] [Related]

  • 10. Role of high-affinity dopamine uptake and impulse activity in the appearance of extracellular dopamine in striatum after administration of exogenous L-DOPA: studies in intact and 6-hydroxydopamine-treated rats.
    Miller DW, Abercrombie ED.
    J Neurochem; 1999 Apr 20; 72(4):1516-22. PubMed ID: 10098856
    [Abstract] [Full Text] [Related]

  • 11. In vivo neurochemical effects of the NR2B selective NMDA receptor antagonist CR 3394 in 6-hydroxydopamine lesioned rats.
    Sarre S, Lanza M, Makovec F, Artusi R, Caselli G, Michotte Y.
    Eur J Pharmacol; 2008 Apr 28; 584(2-3):297-305. PubMed ID: 18342306
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Adenosinergic protection of dopaminergic and GABAergic neurons against mitochondrial inhibition through receptors located in the substantia nigra and striatum, respectively.
    Alfinito PD, Wang SP, Manzino L, Rijhsinghani S, Zeevalk GD, Sonsalla PK.
    J Neurosci; 2003 Nov 26; 23(34):10982-7. PubMed ID: 14645494
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Biotransformation of L-dopa in striatum and substantia nigra of rats with a unilateral, nigrostriatal lesion: a microdialysis study.
    Sarre S, Herregodts P, Deleu D, Devrieze A, De Klippel N, Ebinger G, Michotte Y.
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep 26; 346(3):277-85. PubMed ID: 1407014
    [Abstract] [Full Text] [Related]

  • 16. Coadministration of β-asarone and levodopa increases dopamine in rat brain by accelerating transformation of levodopa: a different mechanism from Madopar.
    Huang L, Deng M, Zhang S, Fang Y, Li L.
    Clin Exp Pharmacol Physiol; 2014 Sep 26; 41(9):685-90. PubMed ID: 24910244
    [Abstract] [Full Text] [Related]

  • 17. Loss of regulation by presynaptic dopamine D2 receptors of exogenous L-DOPA-derived dopamine release in the dopaminergic denervated striatum.
    Maeda T, Kannari K, Suda T, Matsunaga M.
    Brain Res; 1999 Jan 30; 817(1-2):185-91. PubMed ID: 9889362
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. L-DOPA-induced dopamine efflux in the striatum and the substantia nigra in a rat model of Parkinson's disease: temporal and quantitative relationship to the expression of dyskinesia.
    Lindgren HS, Andersson DR, Lagerkvist S, Nissbrandt H, Cenci MA.
    J Neurochem; 2010 Mar 30; 112(6):1465-76. PubMed ID: 20050978
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.